Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause
- 1 April 2013
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 72 (suppl 2) , ii76-ii79
Abstract
Background Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestations in systemic lupus erythematosus (SLE). Objective To describe the patient characteristics of a large cohort of patients with SLE with NP manifestations (NPSLE) in a single centre and to review whether these and other data are compatible with immune-mediated mechanisms. Methods A total of 212 patients were identified from MRI scans of the brain ordered for suspected NPSLE. Data were collected from the medical records. NP syndromes were classified according to the American College of Rheumatology (ACR) nomenclature and case definitions. Results 155 patients fulfilled the criteria for SLE. In 102 patients NP manifestations were attributed to SLE itself (primary NPSLE) whereas, in the remaining patients, the NP symptoms were due to other causes. The median age at the time of SLE diagnosis in patients with primary NPSLE was 27.5 years and the median duration prior to NPSLE was 2.8 years. Forty patients (39%) had a NP manifestation in the first year of the disease. Cerebrovascular disease, cognitive dysfunction, seizures and headache were the most prevalent syndromes. In 47% of patients with primary NPSLE the MRI scan of the brain showed no abnormalities. Conclusions Most NP manifestations in SLE occur early in the disease. This finding, as well as data from quantitative imaging studies and recent pathological studies, point to an immune-mediated pathogenesis.Keywords
This publication has 30 references indexed in Scilit:
- Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort studyArthritis & Rheumatism, 2007
- Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosusArthritis & Rheumatism, 2006
- Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosusArthritis & Rheumatism, 2002
- Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imagingArthritis & Rheumatism, 2000
- Neuroimaging in neuropsychiatric systemic lupus erythematosusArthritis & Rheumatism, 1999
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromesArthritis & Rheumatism, 1999
- A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosusArthritis & Rheumatism, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982